{
    "organizations": [],
    "uuid": "a70fe24f8d43c8fe0ab0258a061ab6554582c8a5",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-zhejiang-hisoar-pharmaceutical-uni/brief-zhejiang-hisoar-pharmaceutical-unit-passes-review-of-high-tech-enterprise-recognition-idUSL4N1P62TO",
    "ord_in_thread": 0,
    "title": "BRIEF-Zhejiang Hisoar Pharmaceutical unit passes review of high-tech enterprise recognition",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 11 (Reuters) - Zhejiang Hisoar Pharmaceutical Co Ltd :\n* Says its pharma unit passed the review of high-tech enterprise recognition and will enjoy a tax preference of 15 percent for three years since 2017\nSource text in Chinese: goo.gl/Zi65ck\nFurther company coverage: (Beijing Headline News)\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-01-11T15:57:00.000+02:00",
    "crawled": "2018-01-12T18:47:28.022+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "zhejiang",
        "hisoar",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "pharma",
        "unit",
        "passed",
        "review",
        "enterprise",
        "recognition",
        "enjoy",
        "tax",
        "preference",
        "percent",
        "three",
        "year",
        "since",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}